Immunogenicity of a DNA vaccine candidate for COVID-19.

Nature Communications
Trevor R F SmithKate E Broderick


The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to control further dissemination of the disease. We have previously engineered a synthetic DNA vaccine targeting the MERS coronavirus Spike (S) protein, the major surface antigen of coronaviruses, which is currently in clinical study. Here we build on this prior experience to generate a synthetic DNA-based vaccine candidate targeting SARS-CoV-2 S protein. The engineered construct, INO-4800, results in robust expression of the S protein in vitro. Following immunization of mice and guinea pigs with INO-4800 we measure antigen-specific T cell responses, functional antibodies which neutralize the SARS-CoV-2 infection and block Spike protein binding to the ACE2 receptor, and biodistribution of SARS-CoV-2 targeting antibodies to the lungs. This preliminary dataset identifies INO-4800 as a potential COVID-19 vaccine candidate, supporting further translational study.


Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jian YanDavid B Weiner
Jul 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Zhongyu ZhuDimiter S Dimitrov
Oct 9, 2007·The Journal of Infectious Diseases·Miriam E R DarnellDeborah R Taylor
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fumihiko YasuiMichinori Kohara
Jan 25, 2011·American Journal of Infection Control·Rachel L HulkowerMark D Sobsey
May 3, 2011·Current Opinion in Immunology·Niranjan Y Sardesai, David B Weiner
Oct 12, 2012·Science Translational Medicine·Mark L BagarazziNiranjan Y Sardesai
Sep 1, 2012·Emerging Microbes & Infections·Hsueh-Ling Janice OhYee-Joo Tan
Feb 19, 2016·Science Translational Medicine·Thomas LukeMatthew B Frieman
Oct 5, 2017·The New England Journal of Medicine·Pablo TebasJoel N Maslow
Sep 18, 2018·Science Advances·Darrick CarterSteven G Reed
Nov 24, 2018·Journal of Virological Methods·Osnat RosenKizzmekia S Corbett
May 10, 2019·Human Vaccines & Immunotherapeutics·Jingjing JiangStephanie J Ramos
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jun 9, 2020·BioRxiv : the Preprint Server for Biology·Daniel WrappJason S McLellan

❮ Previous
Next ❯


Jun 2, 2020·ELife·Luke KempWilliam J Sutherland
Jul 15, 2020·The New England Journal of Medicine·Lisa A JacksonUNKNOWN mRNA-1273 Study Group
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Jul 15, 2020·Angewandte Chemie·Tingting YeBruno G De Geest
Sep 12, 2020·Expert Opinion on Drug Discovery·Amer HarkyNaomi Melamed
Sep 30, 2020·Human Vaccines & Immunotherapeutics·Yashpal Singh MalikKuldeep Dhama
Sep 25, 2020·Current Opinion in HIV and AIDS·Yihan WangDongming Zhou
Sep 26, 2020·Frontiers in Pharmacology·Rudra P SahaChiranjib Chakraborty
Sep 20, 2020·International Journal of Molecular Sciences·Arun Samidurai, Anindita Das
Jul 9, 2020·Frontiers in Pharmacology·Colin D FunkAli Ardakani
Jul 28, 2020·International Journal of Molecular Sciences·Alessandra FierabracciPaolo Rossi
Sep 6, 2020·Nature Reviews. Immunology·Mangalakumari JeyanathanZhou Xing
Sep 16, 2020·Human Vaccines & Immunotherapeutics·Rajat MudgalShailly Tomar
Sep 4, 2020·Annals of Clinical Microbiology and Antimicrobials·Ali A RabaanHakan Leblebicioglu
Jul 30, 2020·The New England Journal of Medicine·Kizzmekia S CorbettBarney S Graham
Sep 26, 2020·Frontiers in Immunology·Sana O AlturkiElias K Haddad
Sep 15, 2020·Frontiers in Public Health·Jingchun FanShisan Bao
Oct 8, 2020·Nature Reviews. Microbiology·Ben HuZheng-Li Shi
Oct 5, 2020·Tropical Medicine & International Health : TM & IH·T Wibawa
Sep 17, 2020·Clinical and Experimental Immunology·John S TregoningKatrina M Pollock
Oct 16, 2020·Immunopharmacology and Immunotoxicology·Tushar BaviskarLokesh Kumar Bhatt
Sep 17, 2020·Immunology·Salman M ToorEyad Elkord
Oct 30, 2020·PLoS Neglected Tropical Diseases·Hyeree ChoiKar Muthumani
Oct 31, 2020·Wiener klinische Wochenschrift·Franz X Heinz, Karin Stiasny
Nov 4, 2020·Future Microbiology·Kenneth Lundstrom
Oct 29, 2020·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Christiane Sigrid Eberhardt, Claire-Anne Siegrist
Nov 25, 2020·Human Vaccines & Immunotherapeutics·Tushar YadavShailendra K Saxena
Nov 29, 2020·Signal Transduction and Targeted Therapy·Zezhong LiuShibo Jiang
Dec 10, 2020·Nature Biomedical Engineering·Norbert Pardi, Drew Weissman
Dec 31, 2020·Vaccines·Shilu MathewHadi M Yassine
Jan 6, 2021·The AAPS Journal·Joydeb Majumder, Tamara Minko
Dec 9, 2020·British Journal of Clinical Pharmacology·Ester Calvo Fernández, Lucie Y Zhu
Dec 29, 2020·Advanced Drug Delivery Reviews·Jee Young ChungYoung Jik Kwon
Nov 26, 2020·Computational and Structural Biotechnology Journal·Desh Deepak SinghDharmendra Kumar Yadav
Dec 29, 2020·Biomaterials·David WibowoBernd H A Rehm
Jan 12, 2021·The Journal of Biological Chemistry·Sameer Kumar MalladiRaghavan Varadarajan

❮ Previous
Next ❯

Methods Mentioned


Software Mentioned

GraphPad Prism
QuantStudio 7

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.